MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.000
-0.010 (-0.99%)
Nov 13, 2026, 4:00 PM EST - Market closed
MAIA Biotechnology Employees
MAIA Biotechnology had 13 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes MAIA Biotechnology the 39,653rd largest employer in the world and 5,835th in the United States.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,932,318
Market Cap
60.83M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 13 | 0 | - |
| Dec 31, 2024 | 13 | 0 | - |
| Dec 31, 2023 | 13 | -5 | -27.78% |
| Dec 31, 2022 | 18 | 9 | 100.00% |
| Dec 31, 2021 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 214 |
| XBiotech | 87 |
| Clene | 79 |
| Fortress Biotech | 78 |
| Verrica Pharmaceuticals | 76 |
| Acrivon Therapeutics | 76 |
| Cardiff Oncology | 31 |
| Spero Therapeutics | 25 |
MAIA News
- 1 day ago - Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) - GlobeNewsWire
- 4 days ago - MAIA Biotechnology Quarterly report: Q3 2026 - Filings
- 4 days ago - MAIA Biotechnology Slides: Corporate presentation - Filings
- 5 weeks ago - MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung Cancer - GlobeNewsWire
- 6 weeks ago - Diamond Equity releases update note on MAIA Biotechnology - TheFly
- 7 weeks ago - MAIA Biotechnology files to sell 751,879 shares of common stock for holders - TheFly
- 7 weeks ago - MAIA Biotechnology Registration statement: Registration filing - Filings
- 7 weeks ago - MAIA Biotechnology Expands Pivotal Phase 3 THIO-104 Non-Small Cell Lung Cancer Trial into Spain and Portugal - GlobeNewsWire